Crude incidence rate of any cancer and individual site of cancer among exclusive users of insulin glargine vs. intermediate/long-acting human insulin (HI).
收藏数据链接：
官方服务：
资源简介：
aTotal follow-up person-year for women: 6,558.8 for insulin glargine users and 47,724.6 for HI users.bTotal follow-up person-year for men: 6,458.8 for insulin glargine users and 42,624.4 for HI users.
创建时间：
2015-12-02
